BIOLASE, Inc. (NASDAQ: BIOL) is a medical device company specializing in the design, development and manufacture of laser systems for dentistry. The company’s laser platforms enable minimally invasive dental procedures, combining laser energy with water spray to perform both hard‐tissue and soft‐tissue applications. By integrating advanced laser technology into routine dental care, BIOLASE aims to improve patient comfort, reduce the need for anesthesia and shorten procedure times.
The company’s flagship products include the Waterlase® family of erbium lasers and the Epic™ series of diode lasers. Waterlase systems are indicated for a wide range of applications, including cavity preparation, bone surgery, endodontics, periodontal therapy and oral surgery. Epic diode lasers are used primarily for soft‐tissue procedures such as gum recontouring, pain management and bacterial reduction. BIOLASE also offers a comprehensive portfolio of handpieces, tips and accessories to support clinical workflows and practice growth.
Founded in 1984 and headquartered in Irvine, California, BIOLASE has established a global distribution network that spans North America, Europe, Asia and other international markets. The company works with dental equipment dealers, group purchasing organizations and strategic partners to expand market reach and provide training and support to dental professionals. BIOLASE’s research and development efforts are focused on enhancing laser performance, broadening procedural indications and integrating digital dentistry solutions.
AI Generated. May Contain Errors.
